Abbott Stock''s Rough Patch: What Gives? (NYSE:ABT)
Abbott''s H1 experienced windfall revenues from its COVID-19 tests and is facing headwinds from macro issues. Read here why we feel it is trading at a discount.
Abbott Stock''s Rough Patch: What Gives? (NYSE:ABT)
Abbott''s H1 experienced windfall revenues from its COVID-19 tests and is facing headwinds from macro issues. Read here why we feel it is trading at a discount.